Divya Soni
Overview
Explore the profile of Divya Soni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sambe B, Zobrist S, Sheahan W, Soni D, Diagne A, Sarr I, et al.
medRxiv
. 2024 Dec;
PMID: 39711730
Background: The emergence of -deleted parasites threatens histidine-rich protein 2 (HRP2)-based malaria rapid diagnostic test (RDT) performance. RDTs targeting () lactate dehydrogenase (LDH) may address current product limitations and improve...
2.
Soni D, Upadhayay S, Dhureja M, Arthur R, Kumar P
Inflammopharmacology
. 2024 Jul;
32(5):2921-2941.
PMID: 38992324
"Path to a good mood lies through the gut." This statement seems to imply that it has long been believed that the gut is connected with the brain. Research has...
3.
Kushawaha S, Ashawat M, Soni D, Kumar P, Rimpi , Baldi A
Brain Res
. 2024 Apr;
1834:148906.
PMID: 38570152
Alzherimer's disease (AD) is an age-dependent ubiquitous ailment worldwide with limited therapies that only alleviate the symptoms of AD but do not cure them entirely because of the restricted blood-brain...
4.
Yedke N, Soni D, Kumar P
Fundam Clin Pharmacol
. 2023 Dec;
38(3):538-549.
PMID: 38041521
Background: Parkinson's disease (PD) is an extrapyramidal movement disorder associated with a hypokinetic condition generated by impairment in dopaminergic neuronal viability in the nigrostriatal region of the brain. Current medications...
5.
Dhureja M, Arthur R, Soni D, Upadhayay S, Temgire P, Kumar P
Expert Opin Ther Targets
. 2023 Nov;
27(11):1159-1172.
PMID: 37971192
Introduction: Recent neuroscience breakthroughs have shed light on the sophisticated relationship between calcium channelopathies and movement disorders, exposing a previously undiscovered tale focusing on the Ryanodine Receptor (RyR) and the...
6.
Gupta R, Soni D, Upadhayay S, Dhureja M, Kumar P
Clin Exp Pharmacol Physiol
. 2023 Sep;
50(12):984-991.
PMID: 37724453
Epilepsy is caused by an excessive recurrent excitatory neuronal firing, characterized by motor, psychomotor, and sensory impairments. Current therapies fail to produce 100% outcomes because of the complexity of the...
7.
Kumar M, Nguyen T, Kaur J, Singh T, Soni D, Singh R, et al.
Pharmacol Rep
. 2023 Jan;
75(1):3-18.
PMID: 36624355
Artificial intelligence (AI) is a machine science that can mimic human behaviour like intelligent analysis of data. AI functions with specialized algorithms and integrates with deep and machine learning. Living...
8.
Upadhayay S, Arthur R, Soni D, Yadav P, Navik U, Singh R, et al.
Int Immunopharmacol
. 2022 Nov;
113(Pt A):109382.
PMID: 36330915
Monkeypox is a zoonotic illness caused by the monkeypox virus (MPXV) that has a similar etiology to smallpox. The first case of monkeypox was reported in Western and Central Africa...
9.
Mundkar M, Bijalwan A, Soni D, Kumar P
J Food Biochem
. 2022 Oct;
46(12):e14451.
PMID: 36206551
Moringa oleifera is a traditional Indian herb belonging to the Moringaceae family, it is commonly known as the horse-radish tree, drumstick, or sahajna. In developing countries, Moringa is used as...
10.
Soni D, Kumar P
Pharmacol Rep
. 2022 Jul;
74(4):557-569.
PMID: 35882765
Movement disorders are neurological conditions characterized by involuntary motor movements, such as dystonia, ataxia, chorea myoclonus, tremors, Huntington's disease (HD), and Parkinson's disease (PD). It is classified into two categories:...